Impact of Therapist Change on Dropout in a Naturalistic Sample of Inpatients With Borderline Pathology Receiving DBT
Completed
- Conditions
- PostTraumatic Stress DisorderPsychotherapyBorderline Personality DisorderDropout
- Interventions
- Behavioral: Dialectical Behavior Therapy
- Registration Number
- NCT03018639
- Lead Sponsor
- Evangelisches Krankenhaus Bielefeld gGmbH
- Brief Summary
Participants with Borderline pathology (≥ 3 DSM-IV-criteria) receiving an inpatient Dialectical Behavior Therapy (DBT) program completed a quality assurance questionnaire set assessing demographic information and pretreatment psychopathology during the days of their inpatient stay. Beyond that, changes of therapists were documented.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 89
Inclusion Criteria
- three or more criteria for BPD as defined by DSM-IV (Borderline Personality characteristics; BPC)
Exclusion Criteria
- inability to contract and consent,
- other severe mental disorders (bipolar disorder, acute psychosis),
- current alcohol,
- illicit or not prescribed drug use,
- simultaneous participation in other treatment studies,
- pregnancy or breastfeeding,
- an inability to negotiate a non-suicide agreement,
- ongoing traumatic contact with the perpetrator, and
- a Body Mass Index < 16.5.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Dialectical Behavior Therapy Dialectical Behavior Therapy The program's purpose is to help patients achieve the following therapeutic goals: (1) reduction of suicidal behaviors, (2) reduction of therapy-interfering behaviors, and (3) other risky or destabilizing behaviors. Standard DBT aims to achieve these goals by (1) conveying behavioral capabilities (skills), (2) motivation for applying these skills, (3) generalization of learned skills to the patient's natural environment, (4) structuring the treatment environment to reinforce functional behavior, and (5) conveying therapeutic resources and motivation to effectively treat patients with BPD.
- Primary Outcome Measures
Name Time Method Dropout 10 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Research Department
🇩🇪Bielefeld, Germany